In this investigation, the results illustrated a decrease in p-AMPK/AMPK levels and high mature SREBP-1c levels in NAFLD, which was reversed by EMF exposure. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.